{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:16:31Z","timestamp":1788315391573,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science & ICT, Republic of Korea","award":["RS-2024-00344521"],"award-info":[{"award-number":["RS-2024-00344521"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01536-2","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:02:20Z","timestamp":1723716140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders"],"prefix":"10.1186","volume":"16","author":[{"given":"Ye Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwon","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Hoon","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-nae","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoojin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"1536_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen Z-R, Huang J-B, Yang S-L, Hong F-F. Role of Cholinergic Signaling in Alzheimer\u2019s Disease. Molecules. 2022;27:1816.","journal-title":"Molecules"},{"key":"1536_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/jnc.15471","volume":"158","author":"C Geula","year":"2021","unstructured":"Geula C, Dunlop SR, Ayala I, Kawles AS, Flanagan ME, Gefen T, et al. Basal forebrain cholinergic system in the dementias: vulnerability, resilience, and resistance. J Neurochem. 2021;158:1394\u2013411.","journal-title":"J Neurochem"},{"issue":"7","key":"1536_CR3","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/brain\/awac096","volume":"145","author":"E Giacobini","year":"2022","unstructured":"Giacobini E, Cuello AC, Fisher A. Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain. 2022;145(7):2250\u201375.","journal-title":"Brain"},{"issue":"5","key":"1536_CR4","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/brain\/awac385","volume":"146","author":"M Nemy","year":"2023","unstructured":"Nemy M, Dyrba M, Brosseron F, Buerger K, Dechent P, Dobisch L, et al. Cholinergic white matter pathways along the Alzheimer\u2019s disease continuum. Brain. 2023;146(5):2075\u201388.","journal-title":"Brain"},{"key":"1536_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain. 2018;141:165\u201376.","journal-title":"Brain"},{"key":"1536_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/brain\/awaa012","volume":"143","author":"S Fern\u00e1ndez-Cabello","year":"2020","unstructured":"Fern\u00e1ndez-Cabello S, Kronbichler M, Dijk KRAV, Goodman JA, Spreng RN, Schmitz TW, et al. Basal forebrain volume reliably predicts the cortical spread of Alzheimer\u2019s degeneration. Brain. 2020;143:993\u20131009.","journal-title":"Brain"},{"key":"1536_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jalz.2008.04.005","volume":"4","author":"AM Hall","year":"2008","unstructured":"Hall AM, Moore RY, Lopez OL, Kuller L, Becker JT. Basal forebrain atrophy is a presymptomatic marker for Alzheimer\u2019s disease. Alzheimers Dement. 2008;4:271\u20139.","journal-title":"Alzheimers Dement"},{"key":"1536_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms13249","volume":"7","author":"TW Schmitz","year":"2016","unstructured":"Schmitz TW, Spreng RN. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer\u2019s pathology. Nat Comm. 2016;7:1\u201313.","journal-title":"Nat Comm"},{"key":"1536_CR9","doi-asserted-by":"crossref","unstructured":"Teipel SJ, Cavedo E, Hampel H, Grothe MJ, Initiative ADN, (APMI), APMI et al. Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer\u2019s Disease Treated With Cholinesterase Inhibitors. Front Neurol. 2018;9:642.","DOI":"10.3389\/fneur.2018.00642"},{"key":"1536_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-122320","volume":"35","author":"H-J Kim","year":"2013","unstructured":"Kim H-J, Moon W-J, Han S-H. Differential Cholinergic pathway involvement in Alzheimer\u2019s Disease and Subcortical ischemic vascular dementia. J Alzheimer\u2019s Dis. 2013;35:129\u201336.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1536_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnagi.2017.00047","volume":"9","author":"Q Liu","year":"2017","unstructured":"Liu Q, Zhu Z, Teipel SJ, Yang J, Xing Y, Tang Y, et al. White matter damage in the Cholinergic System contributes to cognitive impairment in subcortical vascular cognitive impairment, no dementia. Front Aging Neurosci. 2017;9:47.","journal-title":"Front Aging Neurosci"},{"key":"1536_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"DS Auld","year":"2002","unstructured":"Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 2002;68:209\u201345.","journal-title":"Prog Neurobiol"},{"key":"1536_CR13","first-page":"427","volume":"29","author":"S Kar","year":"2004","unstructured":"Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer\u2019s disease. J Psychiatry Neurosci. 2004;29:427\u201341.","journal-title":"J Psychiatry Neurosci"},{"key":"1536_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nicl.2014.11.015","volume":"7","author":"GM Kerbler","year":"2015","unstructured":"Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, et al. Basal forebrain atrophy correlates with amyloid \u03b2 burden in Alzheimer\u2019s disease. Neuroimage Clin. 2015;7:105\u201313.","journal-title":"Neuroimage Clin"},{"key":"1536_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12779\/dnd.2023.22.1.1","volume":"22","author":"HJ Ryu","year":"2023","unstructured":"Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment. Dement Neurocognitive Disord. 2023;22:1\u201315.","journal-title":"Dement Neurocognitive Disord"},{"key":"1536_CR16","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1016\/j.jalz.2013.01.002","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association. Alzheimers Dement. 2013;9:E1\u201316.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1536_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, et al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10(5):424\u201335.","journal-title":"Lancet Neurol"},{"key":"1536_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/diagnostics12030623","volume":"12","author":"J Lee","year":"2022","unstructured":"Lee J, Ha S, Kim REY, Lee M, Kim D, Lim HK. Development of amyloid PET analysis Pipeline using deep learning-based brain MRI Segmentation\u2014A comparative validation study. Diagnostics. 2022;12:623.","journal-title":"Diagnostics"},{"key":"1536_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nicl.2017.04.025","volume":"15","author":"S Bullich","year":"2017","unstructured":"Bullich S, Seibyl J, Catafau AM, Jovalekic A, Koglin N, Barthel H, et al. Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. NeuroImage: Clin. 2017;15:325\u201332.","journal-title":"NeuroImage: Clin"},{"key":"1536_CR20","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","volume":"121","author":"NR Selden","year":"1998","unstructured":"Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121:2249\u201357.","journal-title":"Brain"},{"key":"1536_CR21","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1161\/01.STR.0000183615.07936.b6","volume":"36","author":"C Bocti","year":"2005","unstructured":"Bocti C, Swartz RH, Gao F-Q, Sahlas DJ, Behl P, Black SE. A New Visual Rating Scale to assess Strategic White Matter Hyperintensities within Cholinergic pathways in Dementia. Stroke. 2005;36:2126\u201331.","journal-title":"Stroke"},{"key":"1536_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/archneur.64.2.266","volume":"64","author":"P Behl","year":"2007","unstructured":"Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, et al. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Arch Neurol. 2007;64:266\u201372.","journal-title":"Arch Neurol"},{"key":"1536_CR23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"SM Gregoire","year":"2009","unstructured":"Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73:1759\u201366.","journal-title":"Neurology"},{"key":"1536_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","volume":"41","author":"FN Doubal","year":"2010","unstructured":"Doubal FN, MacLullich AMJ, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged Perivascular spaces on MRI are a feature of Cerebral Small Vessel Disease. Stroke. 2010;41:450\u20134.","journal-title":"Stroke"},{"key":"1536_CR25","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228\u201334.","journal-title":"Neurology"},{"key":"1536_CR26","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","volume":"43","author":"F Fazekas","year":"1993","unstructured":"Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683\u20131683.","journal-title":"Neurology"},{"key":"1536_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13317-019-0117-5","volume":"10","author":"A Andravizou","year":"2019","unstructured":"Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z, et al. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. AutoImmun Highlights. 2019;10:1\u201325.","journal-title":"AutoImmun Highlights"},{"key":"1536_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2010.01.002","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Multiple sclerosis\u2013candidate mechanisms underlying CNS atrophy. Trends Neurosci. 2010;33:202\u201310.","journal-title":"Trends Neurosci"},{"key":"1536_CR29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1212\/WNL.0b013e3182749f39","volume":"79","author":"M Duering","year":"2012","unstructured":"Duering M, Righart R, Csanadi E, Jouvent E, Herv\u00e9 D, Chabriat H, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology. 2012;79:2025\u20138.","journal-title":"Neurology"},{"key":"1536_CR30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/brain\/aww009","volume":"139","author":"C Lambert","year":"2016","unstructured":"Lambert C, Benjamin P, Zeestraten E, Lawrence AJ, Barrick TR, Markus HS. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease. Brain. 2016;139:1136\u201351.","journal-title":"Brain"},{"key":"1536_CR31","doi-asserted-by":"publisher","first-page":"760360","DOI":"10.3389\/fnhum.2022.760360","volume":"16","author":"Z Cao","year":"2022","unstructured":"Cao Z, Mai Y, Fang W, Lei M, Luo Y, Zhao L, et al. The correlation between White Matter Hyperintensity Burden and Regional Brain Volumetry in patients with Alzheimer\u2019s Disease. Front Hum Neurosci. 2022;16:760360.","journal-title":"Front Hum Neurosci"},{"key":"1536_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-170573","volume":"63","author":"EVD Berg","year":"2018","unstructured":"Berg EVD, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP. White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer\u2019s disease: a domain-specific meta-analysis. J Alzheimers Dis. 2018;63:515\u201327.","journal-title":"J Alzheimers Dis"},{"key":"1536_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/BF01271206","volume":"103","author":"H Tohgi","year":"1996","unstructured":"Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm. 1996;103:1211\u201320.","journal-title":"J Neural Transm"},{"issue":"5","key":"1536_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/acn3.51769","volume":"10","author":"C Gan","year":"2023","unstructured":"Gan C, Cao X, Wang L, Sun H, Ji M, Zhang H, et al. Cholinergic basal forebrain atrophy in Parkinson\u2019s disease with freezing of gait. Ann Clin Transl Neurol. 2023;10(5):814\u201324.","journal-title":"Ann Clin Transl Neurol"},{"key":"1536_CR35","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00415-014-7439-z","volume":"261","author":"MJ Grothe","year":"2014","unstructured":"Grothe MJ, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer\u2019s disease dementia. J Neurol. 2014;261:1939\u201348.","journal-title":"J Neurol"},{"key":"1536_CR36","doi-asserted-by":"crossref","unstructured":"Lanct\u00f4t KL, Lindsay MP, Smith EE, Sahlas DJ, Foley N, Gubitz G et al. Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue following Stroke, 6th edition update 2019. Int J Stroke. 2019;15:668\u201388.","DOI":"10.1177\/1747493019847334"},{"key":"1536_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic Criteria for Vascular Cognitive disorders. Alz Dis Assoc Dis. 2014;28:206\u201318.","journal-title":"Alz Dis Assoc Dis"},{"key":"1536_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuroimage.2008.05.055","volume":"42","author":"L Zaborszky","year":"2008","unstructured":"Zaborszky L, Hoemke L, Mohlberg H, Schleicher A, Amunts K, Zilles K. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. NeuroImage. 2008;42:1127\u201341.","journal-title":"NeuroImage"},{"key":"1536_CR39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3174\/ajnr.A7950","volume":"44","author":"DJ Doss","year":"2023","unstructured":"Doss DJ, Johnson GW, Narasimhan S, Shless JS, Jiang JW, Gonz\u00e1lez HFJ, et al. Deep learning segmentation of the Nucleus Basalis of meynert on 3T MRI. Am J Neuroradiol. 2023;44:1020\u20135.","journal-title":"Am J Neuroradiol"},{"key":"1536_CR40","doi-asserted-by":"publisher","first-page":"781938","DOI":"10.3389\/fnagi.2022.781938","volume":"14","author":"W Zhang","year":"2022","unstructured":"Zhang W, Lu J, Qing Z, Zhang X, Zhao H, Bi Y, et al. Effects of Subcortical Atrophy and Alzheimer\u2019s Pathology on Cognition in Elderly Type 2 diabetes: the Alzheimer\u2019s Disease Neuroimaging Initiative Study. Front Aging Neurosci. 2022;14:781938.","journal-title":"Front Aging Neurosci"},{"key":"1536_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00415-006-0238-4","volume":"254","author":"MJ Firbank","year":"2007","unstructured":"Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O\u2019Brien JT, Ford GA. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. J Neurol. 2007;254:713.","journal-title":"J Neurol"},{"key":"1536_CR42","first-page":"57","volume":"21","author":"H Petrovitch","year":"2000","unstructured":"Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging study. Neurobiol Aging. 2000;21:57\u201362.","journal-title":"Neurobiol Aging"},{"key":"1536_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamaneurol.2013.217","volume":"70","author":"HM Jochemsen","year":"2013","unstructured":"Jochemsen HM, Muller M, Visseren FL, Scheltens P, Vincken KL, Mali WP, et al. Blood pressure and progression of brain atrophy: the SMART-MR Study. JAMA Neurol. 2013;70:1046\u201353.","journal-title":"JAMA Neurol"},{"key":"1536_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3988\/jcn.2022.0021","volume":"19","author":"K Baik","year":"2023","unstructured":"Baik K, Jeon S, Yang S-J, Na Y, Chung SJ, Yoo HS, et al. Cortical thickness and brain glucose metabolism in healthy aging. J Clin Neurol. 2023;19:138\u201346.","journal-title":"J Clin Neurol"},{"key":"1536_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13195-022-00973-1","volume":"14","author":"F Cieri","year":"2022","unstructured":"Cieri F, Zhuang X, Cordes D, Kaplan N, Cummings J, Caldwell J, et al. Relationship of sex differences in cortical thickness and memory among cognitively healthy subjects and individuals with mild cognitive impairment and Alzheimer disease. Alzheimer\u2019s Res Ther. 2022;14:36.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1536_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Dimech AS, Chadha AS, et al. Sex differences in Alzheimer disease \u2014 the gateway to precision medicine. Nat Rev Neurol. 2018;14:457\u201369.","journal-title":"Nat Rev Neurol"},{"key":"1536_CR47","doi-asserted-by":"publisher","first-page":"109041","DOI":"10.1016\/j.isci.2024.109041","volume":"27","author":"Y Shi","year":"2024","unstructured":"Shi Y, Cui D, Sun F, OuYang Z, Dou R, Jiao Q, et al. Exploring sexual dimorphism in basal forebrain volume changes during aging and neurodegenerative diseases. iScience. 2024;27:109041.","journal-title":"iScience"},{"key":"1536_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.trci.2019.09.017","volume":"5","author":"JT Gladman","year":"2019","unstructured":"Gladman JT, Corriveau RA, Debette S, Dichgans M, Greenberg SM, Sachdev PS, et al. Vascular contributions to cognitive impairment and dementia: research consortia that focus on etiology and treatable targets to lessen the burden of dementia worldwide. Alzheimer\u2019s Dement: Transl Res Clin Interv. 2019;5:789\u201396.","journal-title":"Alzheimer\u2019s Dement: Transl Res Clin Interv"},{"key":"1536_CR49","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia. Stroke. 2011;42:2672\u2013713.","journal-title":"Stroke"},{"key":"1536_CR50","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1212\/01.WNL.0000055927.22611.EB","volume":"60","author":"M Mesulam","year":"2003","unstructured":"Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state. Neurology. 2003;60:1183\u20135.","journal-title":"Neurology"},{"key":"1536_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/01.STR.0000251787.90695.05","volume":"38","author":"JS Keverne","year":"2007","unstructured":"Keverne JS, Low WCR, Ziabreva I, Court JA, Oakley AE, Kalaria RN. Cholinergic neuronal deficits in CADASIL. Stroke. 2007;38:188\u201391.","journal-title":"Stroke"},{"key":"1536_CR52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in probable Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01536-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:06:46Z","timestamp":1723716406000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01536-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01536-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the study\u2019s retrospective nature and the low risk to participants, the Institutional Review Board of Asan Medical Center approved the protocol and waived patient consent (#2022\u2009\u2212\u20091010). All methods were performed in accordance with the relevant guidelines and regulations of the Asan Medical Center Ethics Committee and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}